BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7038008)

  • 1. Opsonization of serum-sensitive and serum-resistant Escherichia coli by rough mutant (Re) antisera.
    Crowley JP; Zinner SH; Peter G
    J Lab Clin Med; 1982 Feb; 99(2):197-205. PubMed ID: 7038008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opsonic activity of serum and whey from cows immunized with the ferric citrate receptor.
    Wise AJ; Hogan JS; Takemura K; Smith KL
    J Dairy Sci; 2003 Jan; 86(1):146-51. PubMed ID: 12613859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies raised against rough mutants of Escherichia coli and Salmonella strains are opsonic only in the presence of complement.
    Vreede RW; Marcelis JH; Verhoef J
    Infect Immun; 1986 Jun; 52(3):892-6. PubMed ID: 3519464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal and opsonic activities of normal sheep serum against gram-negative bacteria.
    Mittal KR; Ingram DG
    Am J Vet Res; 1975 Aug; 36(08):1189-93. PubMed ID: 1098532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the opsonic capacity of core lipopolysaccharide antiserum of equine origin against smooth Escherichia coli 0111:B4, using macrophage chemiluminescence.
    Morris DD; Harmon BG; Moore JN
    Am J Vet Res; 1989 Aug; 50(8):1272-8. PubMed ID: 2675693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional role of antibody against "core" glycolipid of Enterobacteriaceae.
    Young LS; Stevens P; Ingram J
    J Clin Invest; 1975 Oct; 56(4):850-61. PubMed ID: 1099119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the opsonic activity of polyclonal and monoclonal antibodies raised against Salmonella minnesota strain R595.
    Mehta ND; Wilson BM; Rapson NT; Easmon CS
    J Med Microbiol; 1988 Feb; 25(2):85-93. PubMed ID: 2448462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of anti-human neutrophil antibodies in vitro. Quantitative studies.
    Boxer LA; Stossel TP
    J Clin Invest; 1974 Jun; 53(6):1534-45. PubMed ID: 4208468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum factors capable of opsonizing Shigella for phagocytosis by polymorphonuclear neutrophils.
    Reed WP
    Immunology; 1975 Jun; 28(6):1051-9. PubMed ID: 1132888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activating and opsonic capacity of monoclonal antibodies raised against Escherichia coli O111 and its rough mutant J5.
    Vreede RW; Leuvenink J; Bouter AS; Brouwer EC; Marcelis JH; Verhoef J
    Eur J Clin Microbiol; 1986 Apr; 5(2):141-7. PubMed ID: 3522225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-protective immunity to Gram-negative bacilli: studies with core glycolipid of Salmonella minnesota and antigens of Streptococcus pneumoniae.
    Young LS; Stevens P
    J Infect Dis; 1977 Aug; 136 Suppl():S174-80. PubMed ID: 19538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intravenous immunoglobulin on E. coli opsonization in multiple myeloma.
    Hertler AA; Ross SC
    J Clin Lab Immunol; 1986 Dec; 21(4):177-81. PubMed ID: 3550092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative importance of Salmonella-specific antibody isotypes in phagocytosis of Salmonella typhimurium by ovine mammary neutrophils.
    Mukkur TK; Inman FP
    Res Vet Sci; 1989 Mar; 46(2):153-9. PubMed ID: 2649949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of C3 and IgG proteolysis enhances phagocytosis of Porphyromonas gingivalis.
    Cutler CW; Arnold RR; Schenkein HA
    J Immunol; 1993 Dec; 151(12):7016-29. PubMed ID: 8258706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternofetal transfer of IgG anti-Escherichia coli antibodies with enhanced avidity and opsonic activity in very premature neonates.
    Sennhauser FH; Balloch A; Macdonald RA; Shelton MJ; Roberton DM
    Pediatr Res; 1990 Apr; 27(4 Pt 1):365-71. PubMed ID: 2188203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired opsonization by serum from patients with chronic liver disease.
    Wyke RJ; Rajkovic IA; Williams R
    Clin Exp Immunol; 1983 Jan; 51(1):91-8. PubMed ID: 6339126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic and immunogenic characteristics of subcellular fractions and whole cells of a rough E. coli 0111 (J5) mutant.
    Sakulramrung R; Domingue GJ
    Immunobiology; 1985 May; 169(4):372-88. PubMed ID: 2408995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of phagocytosis of alpha hemolytic strains of Escherichia coli using the fluorescence method].
    Siegfried L; Puzová H; Hlaucová J; Durovicová J
    Cesk Epidemiol Mikrobiol Imunol; 1989 Jul; 38(4):204-8. PubMed ID: 2676198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escherichia coli antibodies in opsonisation and protection against infection.
    van Dijk WC; Verbrugh HA; van Erne-van der Tol ME; Peters R; Verhoef J
    J Med Microbiol; 1981 Nov; 14(4):381-9. PubMed ID: 7031250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.